Medicine VAT Increases Meet Opposition

Mexican government proposals to increase value-added tax (VAT) on medicines have been met with opposition from the Association of Pharmacies of Mexico (Anafarmex), which claims that this would reduce patients' access to drugs. BMI concurs that taxing medicines is a poor solution to wider economic problems and that pricing out low-income groups will put pressure on the already-strained public finances to roll out the Seguro Popular health insurance scheme.

To read the full article, please choose one of the following options: